에서 실시간으로 운영 중이에요!
자세히 알아보기
BCEL
Atreca
BCEL
BCEL
상장 폐지됨
BCEL 종목은 2024년 3월 18일에 상장 폐지됐어요.
소개: Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
직원 수: 90
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
0%
부정적
0%
Lightweight Charts™를 사용해 가격 차트를 구현했어요.